John Dougherty

9PUBLICATIONS
3CO-AUTHORS
Food properties (incl. characteristics and health benefits)HaematologyMicrobial taxonomyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 18, 2024
Resmetirom: The First Food and Drug Administration-Approved Medication for Nonalcoholic Steatohepatitis (NASH).

Erenie Guirguis, John Dougherty, Krisy Thornby

|Nov 18, 2023
Valoctocogene Roxaparvovec and Etranacogene Dezaparavovec: Novel Gene Therapies for Hemophilia A and B.

John A Dougherty, Kristiann M Dougherty

|Jul 14, 2021
Antibiotic Approvals in the Last Decade: Are We Keeping Up With Resistance?

Elias B Chahine, John A Dougherty, Krisy-Ann Thornby

|Dec 15, 2020
Managing Multiple Myeloma in the Face of Drug-Induced Adverse Drug Reaction.

John A Dougherty, Christopher T Elder

|Nov 04, 2020
Osilodrostat: A Novel Steroidogenesis Inhibitor to Treat Cushing's Disease.

John A Dougherty, Divya Sanjaykumar Desai, Javier Barrios Herrera

|Jul 29, 2020
Peanut Allergen Powder-dnfp: A Novel Oral Immunotherapy to Mitigate Peanut Allergy.

John A Dougherty, Justin D Wagner, Megan C Stanton

Pageof 2

Frequent Collaborators

3 joint publications

Erenie H Guirguis

3 joint publications

Krisy-Ann Thornby

1 joint publications

Elias B Chahine